Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 159   

Articles published

NVS 72.40 -0.39 (-0.54%)
price chart
What Analysts say about Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) currently trades at $72.72 which is about -1.88% lower than the 52-week high of $73.57.
Broker's Roundup on Rating and Recommendations: Novartis AG (ADR) (NYSE:NVS)  Post Registrar
Novartis AG (ADR) (NVS) Q3 Earnings: What Leerink Expects
Leerink's 2016 EPS estimate for Novartis stands at $4.8 on revenue of $50.5 billion, compared to consensus of $4.7 and $49 billion, respectively.
Novartis AG (ADR) (NVS) is Downgraded by Credit Suisse to Neutral
On the company's financial health, Novartis AG (ADR) reported $1.23 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Oct 25, 2016.
Novartis AG (ADR) (NYSE:NVS) target price raised to $71.91, issued a report ...  Breaking Finance News
Ionis Pharmaceuticals Inc (IONS), Akcea Strike Favorable Deal with Novartis AG ...
Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares were initially up 6% this morning after the biotech firm and its wholly-owned subsidiary Akcea Therapeutics signed an exclusive cardiovascular disease treatment collaborative agreement with Novartis AG ...
Here's What The Novartis AG (ADR) (NYSE:NVS) Deal Means For Conatus ...
It's been a couple of months since NASH last hit the headlines in the biotech space, and it's come around again, this time in the form of a licensing deal.
Novartis AG (ADR) (NVS) Agrees To $50 Million Deal With Conatus ...  Insider Monkey (blog)
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) Updates On Collaboration Contract ...  Journal Transcript
Analyst Viewpoints on Price Reaction History: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) soared 0.24% during previous trade, a total of 1.86M shares exchanged hands compared with its average trading volume of 3.16M shares whereas its relative volume is 0.60.
Zacks Investment Research upgraded Novartis AG (ADR) (NYSE:NVS) to Hold in a ...  Breaking Finance News
Novartis AG (NVS) May Fancy AstraZeneca plc (AZN) for Takoever: Reports
The American depository receipts of AstraZeneca plc (ADR) (NYSE:AZN) traded up over 1% on the New York exchange Friday, after a report suggested that the company may attract a takeover interest from Novartis AG (ADR) (NYSE:NVS). Novartis' ADRs ...
Analyst Review Alert on Price Target: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) plunged -1.50% during previous trade, a total of 5.42M shares exchanged hands compared with its average trading volume of 3.39M shares whereas its relative volume is 1.96.
Traders Alert - Coty, (NYSE:COTY), Novartis, (NYSE:NVS)  Financial Breaking News
Novartis AG (ADR) (NVS) Multiple Sclerosis Molecule: Ray of Hope
Novartis AG (ADR) (NYSE:NVS) investigational molecule for the treatment and management of multiple sclerosis has shown remarkable reduction in the disease progression up to 21%.
Novartis AG (NVS) Seeks M&A as It Mulls Possible Alcon Sale
Novartis AG (ADR) (NYSE:NVS) is planning to enter into mergers and acquisitions as it continues to weigh options for the long-struggling eye-care business Alcon.